Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort

医学 嗜酸性粒细胞增多 肉芽肿伴多发性血管炎 嗜酸性 前瞻性队列研究 队列 内科学 嗜酸性粒细胞增多综合征 嗜酸性粒细胞增多症 回顾性队列研究 疾病 儿科 病理 血管炎
作者
Guillaume Lefèvre,Séverine Bleuse,Mathieu Puyade,Guillaume Moulis,Antoine Néel,Noémie Abisror,Antoine Baudet,Bernard Bonnotte,Jérémie Dion,Antoine Dossier,Maximilien Grall,François Lifermann,Nicolas Limal,Bertrand Lioger,Irène Machelart,Catherine Mohr,Roderau Outh,Viviane Queyrel,Borhane Slama,Ludovic Tréfond
出处
期刊:Allergy [Wiley]
卷期号:80 (4): 1100-1110 被引量:27
标识
DOI:10.1111/all.16463
摘要

BACKGROUND: Hypereosinophilic syndromes (HES) are a heterogenous group of eosinophilic disorders. To date, only retrospective studies of limited sample-size and/or follow-up duration are available. METHODS: The COHESion study is a national prospective multicenter multidisciplinary cohort recruiting both adults or children with the spectrum of eosinophilic disorders (including reactive HE/HES [HE/HES-R], idiopathic HES [HES-I], lymphocytic HES [HES-L], neoplastic HE/HES [HE/HES-N], HE of unknown significance [HE-US], as well as IgG4-related disease [IgG4RD] or ANCA-negative eosinophilic granulomatosis with polyangiitis [EGPA] overlaps). Patients are followed-up yearly. All data about final diagnosis, organ involvement assessments, and outcome profiles in HES-I were captured and analyzed centrally by HES expert centers. RESULTS: From May 2019 to November 2023, 779 patients were included. For this preliminary analysis, 550 cases were available for centralized review (mean ± SD age: 56 ± 18 years, 42% of female patients). The final diagnoses were HES-I (47%), HE/HES-R (16%), HE-US (15%), HE/HES-N (7%), HE/HES-L (6%), IgG4RD (2%), and ANCA-negative EGPA (7%). In the 258 HES-I patients, outcome profiles were classified as follows: 16.3% had a "single-flare" without further relapse, 28.3% had a "relapsing-remitting" disease when there was at least a 6-month period free of symptoms between two flares, 46.1% had a "persistent disease" requiring continuous treatment to avoid relapses (9.3% remained unclassified because of insufficient follow-up). CONCLUSIONS: The COHESion cohort is the first nationwide prospective multicenter study collecting data on the full spectrum of HE/HES disorders. This preliminary analysis confirms that idiopathic HES patients have various outcome profiles, suggesting different underlying pathophysiological mechanisms and the need of patient-specific management. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT04018118.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ku完成签到 ,获得积分10
刚刚
刚刚
刚刚
saber发布了新的文献求助10
刚刚
1秒前
小米发布了新的文献求助10
1秒前
白金之星完成签到 ,获得积分10
1秒前
lincn发布了新的文献求助10
1秒前
共享精神的应助被白白采纳,获得10
1秒前
Yonnn完成签到,获得积分20
1秒前
酷酷班完成签到,获得积分10
1秒前
smile完成签到,获得积分10
1秒前
wangerer完成签到,获得积分10
1秒前
要减肥长颈鹿完成签到,获得积分10
1秒前
专注数据线完成签到,获得积分10
2秒前
水煮电吹风的应助被韶华采纳,获得10
2秒前
浅梦完成签到,获得积分10
3秒前
学阿斗发布了新的文献求助10
3秒前
韩莉莎发布了新的文献求助10
3秒前
李铮发布了新的文献求助10
3秒前
3秒前
下载发布了新的文献求助10
4秒前
4秒前
4秒前
4秒前
cccchen完成签到,获得积分10
4秒前
4秒前
orixero的应助被荔枝烨采纳,获得10
5秒前
害羞慕晴完成签到,获得积分10
5秒前
超级无敌发布了新的文献求助10
6秒前
6秒前
LIULIU完成签到 ,获得积分10
6秒前
zzz完成签到,获得积分20
7秒前
Lucas的应助被夏天冷采纳,获得10
7秒前
活泼小蜜蜂完成签到,获得积分10
7秒前
cxy完成签到,获得积分10
7秒前
tingfeng完成签到,获得积分10
7秒前
Lucas的应助被勤奋的晋鹏采纳,获得10
8秒前
心灵美兔子完成签到,获得积分10
8秒前
野性的惜蕊完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181155
求助须知:如何正确求助?哪些是违规求助? 9571140
关于积分的说明 21816740
捐赠科研通 7777528
什么是DOI,文献DOI怎么找? 3433436
关于科研通互助平台的介绍 2557664
邀请新用户注册赠送积分活动 2479482